TY - JOUR
T1 - Factors Associated with Cancer Screening Among Hopi Men
AU - Batai, Ken
AU - Sanderson, Priscilla R.
AU - Hsu, Chiu Hsieh
AU - Joshweseoma, Lori
AU - Russell, Dana
AU - Joshweseoma, Lloyd
AU - Ojeda, Jordan
AU - Burhansstipanov, Linda
AU - Brown, Sylvia R.
AU - Ami, Delores
AU - Saboda, Kathylynn
AU - Harris, Robin B.
N1 - Funding Information:
This study would not be possible without the support and resolution approval from the Hopi Tribal Council and the Hopi men who are current and former members of the Community Advisory Committee. Above all, we thank all the Hopi male participants for their willingness to participate in the study. The team acknowledges funding support from the National Cancer Institute through Northern Arizona University-University of Arizona Cancer Center (NAU/UAC Partnership for Native American Cancer Prevention (NACP) U54CA143925 (UACC NACP Grant Number U54CA143924)) and Arizona Department of Health Services, Arizona Biomedical Research Commission (Contract to UA: ADHS13-031255/Brown (PI)).
Funding Information:
This study would not be possible without the support and resolution approval from the Hopi Tribal Council and the Hopi men who are current and former members of the Community Advisory Committee. Above all, we thank all the Hopi male participants for their willingness to participate in the study. The team acknowledges funding support from the National Cancer Institute through Northern Arizona University-University of Arizona Cancer Center (NAU/UAC Partnership for Native American Cancer Prevention (NACP) U54CA143925 (UACC NACP Grant Number U54CA143924)) and Arizona Department of Health Services, Arizona Biomedical Research Commission (Contract to UA: ADHS13-031255/Brown (PI)).
Funding Information:
This study received funding from the National Cancer Institute through Northern Arizona University-University of Arizona Cancer Center (NAU/UAC Partnership for Native American Cancer Prevention (NACP) U54CA143925 (UACC NACP Grant Number U54CA143924)) and Arizona Department of Health Services, Arizona Biomedical Research Commission (Contract to UA: ADHS13-031255/Brown (PI)). Acknowledgments
Publisher Copyright:
© 2020, American Association for Cancer Education.
PY - 2022/8
Y1 - 2022/8
N2 - Cancer screening rates remain low among American Indian men, and cancer screening behaviors and barriers to cancer screening among American Indian men are not well understood. This study evaluated cancer screening behaviors in 102 Hopi men who were 50 years of age or older from the Hopi Survey of Cancer and Chronic Disease. Reported cancer screening frequencies were 15.7%, 45.1%, and 35.3% for fecal occult blood test (FOBT), colonoscopy, and prostate-specific antigen (PSA) test, respectively. Among men who reported having had a FOBT, 81.2% had the test more than 1 year ago. Among men who reported a colonoscopy, 60.8% had colonoscopy within the past 3 years. Similarly, among men who reported having had PSA, 72.3% had PSA within the past 3 years. “No one told me” was the most common answer for not undergoing FOBT (33.7%), colonoscopy (48.2%), and PSA (39.4%). Men who reported having had a PSA or digital rectal exam were three times as likely to also report having a FOBT or colonoscopy (odds ratio [OR] 3.19, 95% confidence interval [CI]: 1.21–8.46). Younger age (< 65) was associated with reduced odds of ever having prostate cancer screening (OR 0.28, 95% CI: 0.10–0.77). Ever having colorectal cancer screening and previous diagnosis of cancer increased odds of ever having prostate cancer screening (OR 3.15, 95% CI: 1.13–8.81 and OR 5.28, 95% CI: 1.15–24.18 respectively). This study illustrates the importance of community cancer education for men to improve cancer screening participation.
AB - Cancer screening rates remain low among American Indian men, and cancer screening behaviors and barriers to cancer screening among American Indian men are not well understood. This study evaluated cancer screening behaviors in 102 Hopi men who were 50 years of age or older from the Hopi Survey of Cancer and Chronic Disease. Reported cancer screening frequencies were 15.7%, 45.1%, and 35.3% for fecal occult blood test (FOBT), colonoscopy, and prostate-specific antigen (PSA) test, respectively. Among men who reported having had a FOBT, 81.2% had the test more than 1 year ago. Among men who reported a colonoscopy, 60.8% had colonoscopy within the past 3 years. Similarly, among men who reported having had PSA, 72.3% had PSA within the past 3 years. “No one told me” was the most common answer for not undergoing FOBT (33.7%), colonoscopy (48.2%), and PSA (39.4%). Men who reported having had a PSA or digital rectal exam were three times as likely to also report having a FOBT or colonoscopy (odds ratio [OR] 3.19, 95% confidence interval [CI]: 1.21–8.46). Younger age (< 65) was associated with reduced odds of ever having prostate cancer screening (OR 0.28, 95% CI: 0.10–0.77). Ever having colorectal cancer screening and previous diagnosis of cancer increased odds of ever having prostate cancer screening (OR 3.15, 95% CI: 1.13–8.81 and OR 5.28, 95% CI: 1.15–24.18 respectively). This study illustrates the importance of community cancer education for men to improve cancer screening participation.
KW - American Indians
KW - Cancer screening
KW - Hopi
KW - Men
KW - Native Americans
UR - http://www.scopus.com/inward/record.url?scp=85092894884&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092894884&partnerID=8YFLogxK
U2 - 10.1007/s13187-020-01900-4
DO - 10.1007/s13187-020-01900-4
M3 - Article
C2 - 33083892
AN - SCOPUS:85092894884
SN - 0885-8195
VL - 37
SP - 915
EP - 923
JO - Journal of Cancer Education
JF - Journal of Cancer Education
IS - 4
ER -